Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
diagnostic tests
MedTech
Oxford Nanopore, SeqOne ink rare disease diagnostic partnership
The goal will be to provide an end-to-end platform that applies extra-long nanopore sequencing reads to whole genomes.
Conor Hale
Mar 15, 2024 3:10pm
Exact, Guardant tout next-gen colorectal cancer screening tests
Mar 14, 2024 1:27pm
Eisai backs C2N's Alzheimer's blood tests with up to $15M
Mar 6, 2024 2:54pm
Fierce Medtech's Fierce 15 of 2023
Mar 4, 2024 3:00am
Ginkgo-a-go-go! Bioworks company forges 3 acquisition deals
Feb 28, 2024 10:10am
Alzheimer's blood test matches spinal fluid accuracy in study
Feb 23, 2024 10:40am